MARKET

SCLXW

SCLXW

Scilex Holding Company
NASDAQ
0.1100
0.0000
0.00%
Closed 12:52 12/26 EST
OPEN
0.1101
PREV CLOSE
0.1100
HIGH
0.1110
LOW
0.1100
VOLUME
1.76K
TURNOVER
--
52 WEEK HIGH
0.6500
52 WEEK LOW
0.0375
MARKET CAP
--
P/E (TTM)
-0.0033
1D
5D
1M
3M
1Y
5Y
1D
Scilex Holding Company Secures $22.6 Million Loan from St. James Bank & Trust
Reuters · 4d ago
Weekly Report: what happened at SCLXW last week (1215-1219)?
Weekly Report · 4d ago
Scilex Holding Secures Up to $100 Million Non-Recourse Loan from St. James Bank & Trust
Reuters · 12/17 15:28
Weekly Report: what happened at SCLXW last week (1208-1212)?
Weekly Report · 12/15 09:04
SCILEX HOLDING CO - LOAN AGREEMENT PRINCIPAL AMOUNT INCREASED TO $100 MLN - SEC FILING
Reuters · 12/12 21:23
SCILEX HOLDING CO: AMOUNT OF PLEDGED SECURITIES WAS INCREASED TO 85.8 MLN SHARES OF COMMON STOCK OF DATAVAULT
Reuters · 12/12 21:23
Scilex Holding Company Doubles Loan Facility to $100 Million with St. James Bank & Trust
Reuters · 12/12 21:17
Weekly Report: what happened at SCLXW last week (1201-1205)?
Weekly Report · 12/08 09:04
More
About SCLXW
Scilex Holding Company is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system) 1.8%, is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It also focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. Its second commercial product ELYXYB, is a potential first-line treatment, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults. Its product candidates include SP-102 (SEMDEXA), SP-103 and SP-104. SP-102 is a viscous gel formulation of a used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica. Its SP-103 is a triple-strength formulation of ZTlido, for the treatment of chronic neck pain.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLXW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLXW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLXW stock methods without spending real money on the virtual paper trading platform.